Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease
S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), P. Castellotti (Milan, Italy), M. Ferrarese (Milan, Italy), L. Pancini (Milan, Italy), A. Pasat (Milan, Italy), N. Vanoni (Milan, Italy), M. Spotti (Milan, Italy), E. Mazzola (Milan, Italy), A. Gramegna (Milan, Italy), L. Saderi (Sassari, Italy), C. Perno (Milan, Italy), J. Van Ingen (Nijmegen, Netherlands), L. Codecasa (Milan, Italy), F. Blasi (Milan, Italy)
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), P. Castellotti (Milan, Italy), M. Ferrarese (Milan, Italy), L. Pancini (Milan, Italy), A. Pasat (Milan, Italy), N. Vanoni (Milan, Italy), M. Spotti (Milan, Italy), E. Mazzola (Milan, Italy), A. Gramegna (Milan, Italy), L. Saderi (Sassari, Italy), C. Perno (Milan, Italy), J. Van Ingen (Nijmegen, Netherlands), L. Codecasa (Milan, Italy), F. Blasi (Milan, Italy). Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease. 2936
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: